Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Use of contraception among reproductive-aged women in the United States, 2014 and 2016.F S Rep. 2020; 1: 83-93https://doi.org/10.1016/j.xfre.2020.06.006
- Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.Contraception. 2015; 92: 10-16https://doi.org/10.1016/j.contraception.2015.04.006
- Perforated intraperitoneal intrauterine contraceptive devices: diagnosis, management, and clinical outcomes.J Minim Invasive Gynecol. 2014; 21: 596-601https://doi.org/10.1016/j.jmig.2013.12.123
- Intrauterine device malposition at the internal iliac vessels.J Minim Invasive Gynecol. 2018; 25: 752https://doi.org/10.1016/j.jmig.2017.08.650
- Giant exophytic cystic adenomyosis with a levonorgestrel containing intrauterine device out of the uterine cavity after uterine myomectomy: a case report.World J Clin Cases. 2020; 8: 188-193https://doi.org/10.12998/wjcc.v8.i1.188
- Pathogenesis of endometriosis: the genetic/epigenetic theory.Fertil Steril. 2019; 111: 327-340https://doi.org/10.1016/j.fertnstert.2018.10.013
Conflict of interest: The Division of Family Planning at the University of Colorado receives research funding from Bayer, Merck and Co., Organon and Chemo Research.
Funding: This project did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.